154 related articles for article (PubMed ID: 15032183)
1. First drug for moderate-to-severe Alzheimer's.
FDA Consum; 2004; 38(1):3. PubMed ID: 15032183
[No Abstract] [Full Text] [Related]
2. Rationale for combination therapy with galantamine and memantine in Alzheimer's disease.
Grossberg GT; Edwards KR; Zhao Q
J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):17S-26S. PubMed ID: 16809811
[TBL] [Abstract][Full Text] [Related]
3. Memantine for treatment of moderate to severe Alzheimer's disease.
Perras C
Issues Emerg Health Technol; 2005 Mar; (64):1-4. PubMed ID: 15762015
[TBL] [Abstract][Full Text] [Related]
4. Expanded use of Aricept.
FDA Consum; 2007; 41(1):3. PubMed ID: 17354281
[No Abstract] [Full Text] [Related]
5. Exacerbation of myoclonus by memantine in a patient with Alzheimer disease.
Papageorgiou SG; Kontaxis T; Antelli A; Kalfakis N
J Clin Psychopharmacol; 2007 Aug; 27(4):407-8. PubMed ID: 17632233
[No Abstract] [Full Text] [Related]
6. Tolerability of switching from donepezil to memantine treatment in patients with moderate to severe Alzheimer's disease.
Waldemar G; Hyvärinen M; Josiassen MK; Kørner A; Lehto H; Wetterberg P
Int J Geriatr Psychiatry; 2008 Sep; 23(9):979-81. PubMed ID: 18229874
[No Abstract] [Full Text] [Related]
7. New drug treatment for Alzheimer's disease. SMAC's advice on use of donepezil is contradictory.
Baxter T; Black D; Prempeh H
BMJ; 1998 Oct; 317(7163):946. PubMed ID: 9841011
[No Abstract] [Full Text] [Related]
8. How do we treat people with dementia in Croatia.
Mimica N; Presecki P
Psychiatr Danub; 2010 Jun; 22(2):363-6. PubMed ID: 20562784
[TBL] [Abstract][Full Text] [Related]
9. Improving functioning in patients with Alzheimer's.
J Psychosoc Nurs Ment Health Serv; 1998 May; 36(5):11-2. PubMed ID: 9604834
[No Abstract] [Full Text] [Related]
10. Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
Prasher VP
Int J Geriatr Psychiatry; 2004 Jun; 19(6):509-15. PubMed ID: 15211527
[TBL] [Abstract][Full Text] [Related]
11. Memantine-related psychotic symptoms in a patient with bipolar disorder.
Canan F; Ataoglu A
J Clin Psychiatry; 2010 Jul; 71(7):957. PubMed ID: 20667296
[No Abstract] [Full Text] [Related]
12. Common Alzheimer's drug flunks test of effectiveness. Initial improvements in cognitive ability made by cholinesterase inhibitors soon disappear.
Health News; 2004 Oct; 10(10):11. PubMed ID: 15584119
[No Abstract] [Full Text] [Related]
13. Long-term effects of Alzheimer's disease treatment.
Wimo A
Lancet Neurol; 2015 Dec; 14(12):1145-6. PubMed ID: 26515659
[No Abstract] [Full Text] [Related]
14. Dementia.
Warner J; Butler R; Arya P
Clin Evid; 2004 Dec; (12):1361-90. PubMed ID: 15865724
[No Abstract] [Full Text] [Related]
15. Treatment strategies for the behavioral symptoms of Alzheimer's disease: focus on early pharmacologic intervention.
Beier MT
Pharmacotherapy; 2007 Mar; 27(3):399-411. PubMed ID: 17316151
[TBL] [Abstract][Full Text] [Related]
16. Donepezil for Alzheimer's disease.
Benjamin B; Burns A
Expert Rev Neurother; 2007 Oct; 7(10):1243-9. PubMed ID: 17939763
[TBL] [Abstract][Full Text] [Related]
17. New Alzheimer's drug approved.
Health News; 2003 Dec; 9(12):2. PubMed ID: 14679975
[No Abstract] [Full Text] [Related]
18. Memantine for patients with Alzheimer disease.
Finucane TE
JAMA; 2004 Apr; 291(14):1695; author reply 1695. PubMed ID: 15082684
[No Abstract] [Full Text] [Related]
19. [Concerning the contribution by Thomas Kaiser, Christiane Florack, Heinrich Franz, Peter Sawicki: donepezil in patients with Alzheimer's dementia. The AD2000 study. Med Klin 2005;100:157-60].
Vollmar HC; Butzlaff M
Med Klin (Munich); 2005 Nov; 100(11):771; author reply 771. PubMed ID: 16328187
[No Abstract] [Full Text] [Related]
20. Drug may slow brain shrinkage in pre-Alzheimer's disease.
Mayo Clin Health Lett; 2006 Dec; 24(12):4. PubMed ID: 17304693
[No Abstract] [Full Text] [Related]
[Next] [New Search]
